Related Experiment Video

Updated: Jul 4, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Association analysis of CFH, C2, BF, and HTRA1 gene polymorphisms in Chinese patients with polypoidal choroidal

Kelvin Y Lee1, Eranga N Vithana, Ranjana Mathur

  • 1Singapore National Eye Centre, Singapore.

Investigative Ophthalmology & Visual Science
|June 3, 2008
PubMed

Insights

Genetic variants in CFH and HTRA1 genes are significantly associated with polypoidal choroidal vasculopathy (PCV) risk in Chinese patients. These findings highlight key genetic factors contributing to PCV, a major cause of vision loss.

Area of Science:

  • Ophthalmology
  • Genetics
  • Molecular Biology

Background:

  • Polypoidal choroidal vasculopathy (PCV) is a leading cause of exudative maculopathy in Chinese populations.
  • Age-related macular degeneration (AMD) is associated with genetic variants in CFH, HTRA1, LOC387715, C2, and BF genes, particularly in Caucasian and Chinese cohorts.
  • Understanding the genetic underpinnings of PCV is crucial for identifying at-risk individuals and developing targeted therapies.

Purpose of the Study:

  • To investigate the association between specific genetic variants in CFH, HTRA1/LOC387715, C2, and BF genes and the risk of developing PCV in Chinese patients.
  • To determine if previously identified AMD-associated genetic factors play a role in the pathogenesis of PCV in this ethnic group.

Main Methods:

  • A case-control study was conducted involving 72 Chinese patients diagnosed with PCV and 93 healthy control subjects.
  • Genotyping was performed for five single-nucleotide polymorphisms (SNPs) in the CFH gene, two SNPs each in C2 and BF genes, and two variants in the HTRA1 and LOC387715 genes.
  • Statistical analyses were performed to assess the association between specific genotypes and PCV risk, adjusting for age and sex.

Main Results:

  • Significant associations were found between PCV and CFH variants rs3753394 (P = 0.0015) and rs800292 (P = 0.0045).
  • The homozygous TT genotype of rs3753394 conferred a 4.29-fold increased risk of PCV (P = 0.0076).
  • Significant differences in genotype frequencies were observed for HTRA1 variant rs11200638 (P = 0.00032) and LOC387715 variant rs10490924 (P = 0.003), with associated increased risks of 4.9-fold and 4.89-fold, respectively.
  • No significant associations were found for the CFH Y402H variant (rs1061170) or variants in the BF and C2 genes.

Conclusions:

  • Specific single-nucleotide polymorphisms (SNPs) in the CFH gene (rs3753394, rs800292) and the HTRA1 gene (rs11200638) are significantly associated with an increased risk of polypoidal choroidal vasculopathy (PCV) in Chinese patients.
  • These genetic markers may serve as important indicators for PCV susceptibility in the Chinese population.
  • Further research is warranted to elucidate the functional mechanisms underlying these genetic associations.
Abstract

More Related Videos

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...